The Korea Pharmaceutical Bio Association will hold a win-win exchange meeting for 2025 bio on the 17th
Sep 04, 2025
|
The Bio Win-Win Exchange, which marks its fourth anniversary this year, is a representative venue for exchanges in the pharmaceutical bio industry to solidify the foundation for cooperation and seek practical partnerships by revitalizing open innovation between pharmaceutical companies and bio ventures.
Any pharmaceutical company or bio venture executive can participate through prior registration, and the registration method can be found on the association's website and information official documents.
At this event, domestic pharmaceutical bio companies' open innovation experiences and new technology-based cooperation cases will be unveiled.
Huh Jung-ho, head of GC Green Cross, will present the open innovation experience and lesson learned of GC Green Cross, and Kim Dong-hoon, vice president of Inventory Lab, will introduce the DDS platform technology-based partnership of Inventive Lab.
After the announcement, open networking and dinners will provide a place for participants to freely discuss cooperation opportunities and discover new partnerships.
Through this event, the Korea Pharmaceutical and Bio Association announced that it will contribute to the establishment of an innovative ecosystem to strengthen global competitiveness as well as win-win cooperation between domestic pharmaceutical and bio companies.
This article was translated by Naver AI translator.
